US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist
  • 1.200
  • 0.0000.00%
Close Sep 26 16:00 ET
47.30MMarket Cap-731P/E (TTM)

Barinthus Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
-98.21%802K
0
0
-98.04%334K
-96.88%468K
16,580.22%44.7M
645,800.00%6.46M
32,347.37%6.17M
Operating revenue
--0
--0
-98.21%802K
--0
--0
-98.04%334K
-96.88%468K
16,580.22%44.7M
645,800.00%6.46M
32,347.37%6.17M
Cost of revenue
Gross profit
Operating expense
-32.62%17.59M
-21.52%16.32M
71.05%81.26M
-38.18%19.45M
4,393.95%14.9M
769.82%26.11M
56.17%20.8M
14.50%47.5M
103.56%31.46M
-107.55%-347K
Selling and administrative expenses
-45.15%7.2M
-50.62%5.99M
523.12%39.84M
-29.69%13.62M
108.89%961K
--13.13M
231.37%12.14M
-74.54%6.39M
97.88%19.37M
-1,013.43%-10.82M
-General and administrative expense
-45.15%7.2M
-50.62%5.99M
523.12%39.84M
-29.69%13.62M
108.89%961K
--13.13M
231.37%12.14M
-74.54%6.39M
97.88%19.37M
-1,013.43%-10.82M
Research and development costs
-15.52%10.97M
21.65%10.53M
0.74%41.41M
-51.77%5.83M
33.16%13.94M
45.99%12.98M
-10.32%8.66M
151.13%41.11M
113.35%12.1M
206.80%10.47M
Other operating expenses
---577K
---205K
----
----
----
----
----
----
----
----
Operating profit
31.75%-17.59M
19.71%-16.32M
-2,772.30%-80.45M
22.22%-19.45M
-328.81%-14.9M
-283.33%-25.78M
-1,294.30%-20.33M
93.20%-2.8M
-61.77%-25M
242.28%6.51M
Net non-operating interest income expense
22.64%623K
-51.95%763K
-7.62%2.85M
-56.78%564K
-81.74%189K
-23.26%508K
17,544.44%1.59M
215.68%3.08M
7,350.00%1.31M
1.04M
Non-operating interest income
21.65%635K
-51.20%775K
-7.28%2.88M
-56.87%571K
-81.06%196K
-21.97%522K
1,813.25%1.59M
155,050.00%3.1M
--1.32M
--1.04M
Non-operating interest expense
-14.29%12K
--12K
47.37%28K
--7K
--7K
100.00%14K
--0
-99.29%19K
----
----
Other net income (expense)
-93.55%20K
90.83%1.08M
50.00%774K
-2K
507.84%310K
107.82%567K
54.03%516K
Other non- operating income (expenses)
-93.55%20K
----
90.83%1.08M
50.00%774K
---2K
507.84%310K
----
70.78%567K
54.03%516K
----
Income before tax
32.09%-16.95M
16.98%-15.56M
-9,102.59%-76.52M
21.88%-18.11M
-294.95%-14.71M
-268.95%-24.96M
-1,195.21%-18.74M
101.66%850K
-53.13%-23.18M
264.89%7.55M
Income tax
99.38%-7K
92.83%-37K
31.22%-3.08M
59.39%-820K
10.53%-603K
-24.15%-1.14M
40.21%-516K
-15,867.86%-4.47M
-6,409.38%-2.02M
-9,528.57%-674K
Net income
28.88%-16.94M
14.83%-15.52M
-1,480.32%-73.45M
18.30%-17.29M
-271.63%-14.11M
-251.85%-23.82M
-807.96%-18.22M
110.41%5.32M
-39.50%-21.16M
279.89%8.22M
Net income continuous Operations
28.88%-16.94M
14.83%-15.52M
-1,480.32%-73.45M
18.30%-17.29M
-271.63%-14.11M
-251.85%-23.82M
-807.96%-18.22M
110.41%5.32M
-39.50%-21.16M
279.89%8.22M
Minority interest income
45.45%-12K
27.91%-31K
-376.19%-100K
-88.46%3K
-80.95%-38K
-450.00%-22K
-95.45%-43K
91.50%-21K
144.83%26K
-61.54%-21K
Net income attributable to the parent company
28.87%-16.93M
14.80%-15.49M
-1,473.03%-73.35M
18.39%-17.29M
-270.74%-14.07M
-251.67%-23.8M
-800.31%-18.18M
110.50%5.34M
-40.20%-21.19M
280.86%8.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
28.87%-16.93M
14.80%-15.49M
-1,473.03%-73.35M
18.39%-17.29M
-270.74%-14.07M
-251.67%-23.8M
-800.31%-18.18M
110.50%5.34M
-40.20%-21.19M
280.86%8.24M
Basic earnings per share
30.65%-0.43
16.67%-0.4
-1,464.29%-1.91
21.05%-0.45
-268.18%-0.37
-247.62%-0.62
-785.71%-0.48
107.14%0.14
-50.00%-0.57
269.23%0.22
Diluted earnings per share
30.65%-0.43
16.67%-0.4
-1,464.29%-1.91
21.05%-0.45
-268.18%-0.37
-251.22%-0.62
-805.88%-0.48
107.14%0.14
-50.00%-0.57
269.23%0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00-98.21%802K00-98.04%334K-96.88%468K16,580.22%44.7M645,800.00%6.46M32,347.37%6.17M
Operating revenue --0--0-98.21%802K--0--0-98.04%334K-96.88%468K16,580.22%44.7M645,800.00%6.46M32,347.37%6.17M
Cost of revenue
Gross profit
Operating expense -32.62%17.59M-21.52%16.32M71.05%81.26M-38.18%19.45M4,393.95%14.9M769.82%26.11M56.17%20.8M14.50%47.5M103.56%31.46M-107.55%-347K
Selling and administrative expenses -45.15%7.2M-50.62%5.99M523.12%39.84M-29.69%13.62M108.89%961K--13.13M231.37%12.14M-74.54%6.39M97.88%19.37M-1,013.43%-10.82M
-General and administrative expense -45.15%7.2M-50.62%5.99M523.12%39.84M-29.69%13.62M108.89%961K--13.13M231.37%12.14M-74.54%6.39M97.88%19.37M-1,013.43%-10.82M
Research and development costs -15.52%10.97M21.65%10.53M0.74%41.41M-51.77%5.83M33.16%13.94M45.99%12.98M-10.32%8.66M151.13%41.11M113.35%12.1M206.80%10.47M
Other operating expenses ---577K---205K--------------------------------
Operating profit 31.75%-17.59M19.71%-16.32M-2,772.30%-80.45M22.22%-19.45M-328.81%-14.9M-283.33%-25.78M-1,294.30%-20.33M93.20%-2.8M-61.77%-25M242.28%6.51M
Net non-operating interest income expense 22.64%623K-51.95%763K-7.62%2.85M-56.78%564K-81.74%189K-23.26%508K17,544.44%1.59M215.68%3.08M7,350.00%1.31M1.04M
Non-operating interest income 21.65%635K-51.20%775K-7.28%2.88M-56.87%571K-81.06%196K-21.97%522K1,813.25%1.59M155,050.00%3.1M--1.32M--1.04M
Non-operating interest expense -14.29%12K--12K47.37%28K--7K--7K100.00%14K--0-99.29%19K--------
Other net income (expense) -93.55%20K90.83%1.08M50.00%774K-2K507.84%310K107.82%567K54.03%516K
Other non- operating income (expenses) -93.55%20K----90.83%1.08M50.00%774K---2K507.84%310K----70.78%567K54.03%516K----
Income before tax 32.09%-16.95M16.98%-15.56M-9,102.59%-76.52M21.88%-18.11M-294.95%-14.71M-268.95%-24.96M-1,195.21%-18.74M101.66%850K-53.13%-23.18M264.89%7.55M
Income tax 99.38%-7K92.83%-37K31.22%-3.08M59.39%-820K10.53%-603K-24.15%-1.14M40.21%-516K-15,867.86%-4.47M-6,409.38%-2.02M-9,528.57%-674K
Net income 28.88%-16.94M14.83%-15.52M-1,480.32%-73.45M18.30%-17.29M-271.63%-14.11M-251.85%-23.82M-807.96%-18.22M110.41%5.32M-39.50%-21.16M279.89%8.22M
Net income continuous Operations 28.88%-16.94M14.83%-15.52M-1,480.32%-73.45M18.30%-17.29M-271.63%-14.11M-251.85%-23.82M-807.96%-18.22M110.41%5.32M-39.50%-21.16M279.89%8.22M
Minority interest income 45.45%-12K27.91%-31K-376.19%-100K-88.46%3K-80.95%-38K-450.00%-22K-95.45%-43K91.50%-21K144.83%26K-61.54%-21K
Net income attributable to the parent company 28.87%-16.93M14.80%-15.49M-1,473.03%-73.35M18.39%-17.29M-270.74%-14.07M-251.67%-23.8M-800.31%-18.18M110.50%5.34M-40.20%-21.19M280.86%8.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 28.87%-16.93M14.80%-15.49M-1,473.03%-73.35M18.39%-17.29M-270.74%-14.07M-251.67%-23.8M-800.31%-18.18M110.50%5.34M-40.20%-21.19M280.86%8.24M
Basic earnings per share 30.65%-0.4316.67%-0.4-1,464.29%-1.9121.05%-0.45-268.18%-0.37-247.62%-0.62-785.71%-0.48107.14%0.14-50.00%-0.57269.23%0.22
Diluted earnings per share 30.65%-0.4316.67%-0.4-1,464.29%-1.9121.05%-0.45-268.18%-0.37-251.22%-0.62-805.88%-0.48107.14%0.14-50.00%-0.57269.23%0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data